Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $2.9 million.

  • Rapid Micro Biosystems' Cost of Revenue fell 1424.76% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 1266.64%. This contributed to the annual value of $13.3 million for FY2024, which is 42.04% down from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Cost of Revenue stood at $2.9 million, which was down 1424.76% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Cost of Revenue registered a high of $4.1 million during Q4 2022, and its lowest value of $2.3 million during Q1 2021.
  • For the 5-year period, Rapid Micro Biosystems' Cost of Revenue averaged around $3.3 million, with its median value being $3.3 million (2024).
  • As far as peak fluctuations go, Rapid Micro Biosystems' Cost of Revenue soared by 15258.9% in 2021, and later tumbled by 2335.11% in 2023.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Cost of Revenue stood at $3.4 million in 2021, then increased by 22.92% to $4.1 million in 2022, then dropped by 23.35% to $3.2 million in 2023, then decreased by 5.66% to $3.0 million in 2024, then dropped by 2.92% to $2.9 million in 2025.
  • Its Cost of Revenue was $2.9 million in Q3 2025, compared to $3.1 million in Q2 2025 and $2.8 million in Q1 2025.